tiprankstipranks
ENDRA Life Sciences Inc (NDRA)
NASDAQ:NDRA
US Market
NDRA
ENDRA Life Sciences
RESEARCH TOOLSreports
Want to see NDRA full AI Analyst Report?

ENDRA Life Sciences (NDRA) Ratios

857 Followers

ENDRA Life Sciences Ratios

NDRA's free cash flow for Q4 2025 was $0.00. For the 2025 fiscal year, NDRA's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Dec 23Dec 22
Liquidity Ratios
Current Ratio
 ― 1.29 5.67 3.36 5.00
Quick Ratio
 ― 1.29 5.67 3.36 3.45
Cash Ratio
 ― 1.02 5.34 3.14 2.87
Solvency Ratio
 ― -4.31 -5.97 -8.93 -6.25
Operating Cash Flow Ratio
 ― -6.90 -12.23 -10.57 -7.49
Short-Term Operating Cash Flow Coverage
 ― 0.00 0.00 -335.23 -448.30
Net Current Asset Value
$ ―$ -625.71K$ 1.54M$ 1.94M$ 6.46M
Leverage Ratios
Debt-to-Assets Ratio
 ― 0.13 0.13 0.06 0.06
Debt-to-Equity Ratio
 ― 0.22 0.23 0.07 0.08
Debt-to-Capital Ratio
 ― 0.18 0.19 0.07 0.07
Long-Term Debt-to-Capital Ratio
 ― 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 ― 1.71 1.74 1.19 1.29
Debt Service Coverage Ratio
 ― 0.00 0.00 -343.52 -258.81
Interest Coverage Ratio
 ― 0.00 0.00 0.00 -611.04
Debt to Market Cap
 ― 0.00 0.00 <0.01 <0.01
Interest Debt Per Share
 ― 0.63 0.52 0.23 0.29
Net Debt to EBITDA
 ― 0.05 0.25 0.25 0.34
Profitability Margins
Gross Profit Margin
―0.00%0.00%0.00%0.00%
EBIT Margin
―0.00%0.00%0.00%0.00%
EBITDA Margin
―0.00%0.00%0.00%0.00%
Operating Profit Margin
―0.00%0.00%0.00%0.00%
Pretax Profit Margin
―0.00%0.00%0.00%0.00%
Net Profit Margin
―0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
―0.00%0.00%0.00%0.00%
Net Income Per EBT
―100.00%100.00%100.00%100.00%
EBT Per EBIT
―121.94%106.39%95.62%100.16%
Return on Assets (ROA)
―-182.35%-258.47%-148.95%-142.11%
Return on Equity (ROE)
―-310.93%-449.46%-177.77%-182.93%
Return on Capital Employed (ROCE)
―-185.74%-281.17%-179.81%-173.80%
Return on Invested Capital (ROIC)
―-178.30%-274.26%-173.80%-169.75%
Return on Tangible Assets
―-182.35%-258.47%-148.95%-142.11%
Earnings Yield
―-197.11%-163.78%-0.16%-0.10%
Efficiency Ratios
Receivables Turnover
 ― 0.00 0.00 0.00 0.00
Payables Turnover
 ― 0.00 0.00 0.76 0.38
Inventory Turnover
 ― 0.00 0.00 0.00 0.09
Fixed Asset Turnover
 ― 0.00 0.00 0.00 0.00
Asset Turnover
 ― 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
 ― 0.00 0.00 0.00 0.00
Cash Conversion Cycle
 ― 0.00 0.00 -477.57 3.16K
Days of Sales Outstanding
 ― 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 ― 0.00 0.00 0.00 4.12K
Days of Payables Outstanding
 ― 0.00 0.00 477.57 956.62
Operating Cycle
 ― 0.00 0.00 0.00 4.12K
Cash Flow Ratios
Operating Cash Flow Per Share
 ― -6.59 -6.59 -5.59 -6.62
Free Cash Flow Per Share
 ― -6.61 -6.61 -5.61 -6.72
CapEx Per Share
 ― 0.02 0.01 0.02 0.10
Free Cash Flow to Operating Cash Flow
 ― 1.00 1.00 1.00 1.02
Dividend Paid and CapEx Coverage Ratio
 ― -299.92 -348.54 -274.99 -60.70
Capital Expenditure Coverage Ratio
 ― -299.92 -462.53 -281.81 -63.03
Operating Cash Flow Coverage Ratio
 ― -10.53 -12.66 -24.21 -23.36
Operating Cash Flow to Sales Ratio
 ― 0.00 0.00 0.00 0.00
Free Cash Flow Yield
―-145.85%-105.55%-0.15%-0.09%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 ― -0.51 -0.61 -629.86 -1.04K
Price-to-Sales (P/S) Ratio
 ― 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 ― 1.58 2.74 1.12K 1.91K
Price-to-Free Cash Flow (P/FCF) Ratio
 ― -0.69 -0.95 -661.25 -1.06K
Price-to-Operating Cash Flow Ratio
 ― -0.69 -0.95 -663.60 -1.08K
Price-to-Earnings Growth (PEG) Ratio
 ― 0.04 >-0.01 -21.81 63.41
Price-to-Fair Value
 ― 1.58 2.74 1.12K 1.91K
Enterprise Value Multiple
 ― -0.59 -0.41 -647.34 -1.06K
Enterprise Value
 ― 3.30M 4.38M 6.33B 13.74B
EV to EBITDA
 ― -0.59 -0.41 -647.34 -1.06K
EV to Sales
 ― 0.00 0.00 0.00 0.00
EV to Free Cash Flow
 ― -0.63 -0.59 -661.00 -1.06K
EV to Operating Cash Flow
 ― -0.64 -0.59 -663.34 -1.08K
Tangible Book Value Per Share
 ― 2.87 2.28 3.31 3.73
Shareholders’ Equity Per Share
 ― 2.87 2.28 3.31 3.73
Tax and Other Ratios
Effective Tax Rate
 ― 0.00 0.00 0.00 0.00
Revenue Per Share
 ― 0.00 0.00 0.00 0.00
Net Income Per Share
 ― -8.93 -10.25 -5.89 -6.83
Tax Burden
 ― 1.00 1.00 1.00 1.00
Interest Burden
 ― 1.22 1.06 1.00 1.00
Research & Development to Revenue
 ― 0.00 0.00 0.00 0.00
SG&A to Revenue
 ― 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 ― 0.00 0.00 0.00 0.00
Income Quality
 ― 0.74 0.64 0.95 0.97
Currency in USD